1,732 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Abcam Acquisitions

Abcam has acquired 12 companies and its latest acquisition was NKY Biotech US, Inc on Aug 2021

Unlock 9 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

NKY Biotech US, Inc

Aug 2021

Source »
undisclosed
-
BioVision, Inc.

Aug 2021

Source »
$340M
BioVision is a California-based life science company that develops research tools such as bioassay kits, antibodies and enzymes for biopharma and diagnostic sectors.
Marker Gene Technologes, Inc.

Mar 2020

Source »
undisclosed
Marker Gene is a supplier of reagents and enzyme-based assay kits for medical scientists.

-

Gene Editing Platform and Oncology Product Portfolio, Applied StemCell, Inc

Jan 2020

Source »
undisclosed
-
Expedeon, Inc.

Nov 2019

Source »
$132.2M
Expedeon is a provider of bioconjugation products and assay development services for life science and medical diagnostics sectors.

Frequently Asked Questions about Abcam

  1. What companies did Abcam acquire?

    Companies acquired by Abcam include , BioVision and Marker Gene

  2. How many acquisitions does Abcam have?

    Abcam has acquired 12 companies including , BioVision and Marker Gene.

  1. How many acquisitions did Abcam make in 2021?

    In 2021 Abcam acquired 2 companies including and BioVision.